A Valuable Partner
Our unique approach to R&D goes beyond science and makes us an ideal partner for pharmaceutical companies and others working in the HCV and antibacterial arenas. Being nimble, while maintaining focus allows us to work with a variety of partners to bring our research to where it will do the most good.
Today, we are working collaboratively with our partners; AbbVie (the former research-based pharmaceutical business of Abbott Laboratories), Novartis, and the National Institutes of Allergy and Infectious Disease (NIAID), who share our goals of advancing our compounds as quickly as possible in order to treat a variety of serious infections.
Click here to learn more about our partnership opportunities.